# Ashwagandha â€” Most clinically validated adaptogen
slug: ashwagandha
name: Ashwagandha
aliases:
  - withania somnifera
  - indian ginseng
  - KSM-66
  - Sensoril
  - winter cherry
category: ADAPTOGEN
subcategory: herbal_adaptogen
legalStatus: LEGAL
description: |
  Ashwagandha (Withania somnifera) is an Ayurvedic herb and one of the most extensively
  researched adaptogens. It reduces cortisol, modulates the HPA axis, and has demonstrated
  benefits for stress, anxiety, testosterone, muscle recovery, and sleep quality across
  multiple double-blind RCTs. KSM-66 (full-spectrum root extract) and Sensoril (leaf/root
  blend) are the two clinically validated standardized extracts.

halfLife: "~12 hours (withanolides)"
onset: "2-4 weeks for stress and cortisol effects; acute anxiolytic effects within 60-90 min"
duration: "Effects persist with daily use; 2-3 week wash-out to baseline"
routeOfAdmin:
  - oral
mechanismShort: "Withanolides modulate HPA axis, reduce cortisol, potentiate GABA-A signaling, and inhibit NF-kB inflammation"

dosing:
  min: 300
  typical: 600
  max: 1200
  unit: mg
  frequency: "daily (split 2x/day)"
  notes: "Use standardized extract (KSM-66 or Sensoril). Take with food to reduce GI upset. Evening dose supports sleep."

sideEffects:
  - name: GI_upset
    severity: mild
    frequency: uncommon
    notes: "Nausea and loose stools; take with food to resolve"
  - name: drowsiness
    severity: mild
    frequency: uncommon
    notes: "Mild sedation at higher doses; move evening dose to bedtime"
  - name: thyroid_stimulation
    severity: moderate
    frequency: rare
    notes: "May increase T3/T4; monitor thyroid function if on thyroid medication"
  - name: hepatotoxicity
    severity: severe
    frequency: rare
    notes: "Rare case reports of liver injury; discontinue if jaundice or elevated LFTs appear"

interactions:
  - target: l-theanine
    type: synergistic
    severity: mild
    description: "Complementary anxiolytic mechanisms: L-theanine provides acute GABA-A effects, ashwagandha works chronically via HPA modulation"
  - target: magnesium-glycinate
    type: synergistic
    severity: mild
    description: "Additive stress reduction and sleep improvement via distinct mechanisms; both reduce HPA hyperactivity"

mechanisms:
  - pathway: HPA_axis_modulation
    description: "Withanolides suppress corticotropin-releasing hormone (CRH) and ACTH, reducing downstream cortisol secretion"
  - pathway: GABA_A_potentiation
    description: "Withanolide A acts as a positive allosteric modulator of GABA-A receptors, producing anxiolytic effects independent of benzodiazepine sites"
  - pathway: NF_kB_inhibition
    description: "Suppresses NF-kB signaling cascade, reducing pro-inflammatory cytokines (IL-6, TNF-alpha)"
  - pathway: testosterone_support
    description: "Reduces cortisol-mediated testosterone suppression and supports LH secretion; RCT evidence for 15-40% T increase"

searchTerms:
  pubmed:
    - "ashwagandha AND (cortisol OR stress OR anxiety) AND randomized controlled trial"
    - "withania somnifera AND testosterone AND human"
    - "KSM-66 OR Sensoril AND clinical trial AND human"
  semanticScholar:
    - "ashwagandha adaptogen stress cortisol randomized"
    - "withania somnifera testosterone muscle recovery"
